Omega Healthcare Investors (NYSE:OHI) Earns Buy Rating from Analysts at The Goldman Sachs Group

The Goldman Sachs Group initiated coverage on shares of Omega Healthcare Investors (NYSE:OHI) in a report issued on Friday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $54.00 price objective on the real estate investment trust’s stock.

OHI has been the subject of several other reports. Wells Fargo & Company upped their target price on Omega Healthcare Investors from $45.00 to $48.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Truist Financial increased their price objective on shares of Omega Healthcare Investors from $44.00 to $46.00 and gave the company a “hold” rating in a report on Monday, December 1st. Scotiabank lifted their price target on shares of Omega Healthcare Investors from $42.00 to $45.00 and gave the company a “sector perform” rating in a research report on Thursday, November 13th. Jefferies Financial Group reiterated a “hold” rating and set a $45.00 price target on shares of Omega Healthcare Investors in a research report on Monday, December 15th. Finally, Royal Bank Of Canada lifted their target price on Omega Healthcare Investors from $41.00 to $44.00 and gave the company a “sector perform” rating in a research report on Thursday, November 6th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, Omega Healthcare Investors presently has an average rating of “Moderate Buy” and a consensus target price of $47.09.

Omega Healthcare Investors Stock Performance

Shares of OHI opened at $44.27 on Friday. Omega Healthcare Investors has a 12 month low of $35.04 and a 12 month high of $46.36. The stock has a fifty day moving average price of $44.49 and a 200-day moving average price of $41.75. The company has a current ratio of 7.11, a quick ratio of 7.11 and a debt-to-equity ratio of 0.95. The firm has a market cap of $13.08 billion, a PE ratio of 24.73, a P/E/G ratio of 1.88 and a beta of 0.57.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share for the quarter, topping analysts’ consensus estimates of $0.77 by $0.02. Omega Healthcare Investors had a return on equity of 10.72% and a net margin of 46.83%.The business had revenue of $311.59 million for the quarter, compared to analyst estimates of $262.48 million. During the same quarter in the previous year, the firm earned $0.71 earnings per share. The company’s revenue was up 14.4% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. Equities research analysts predict that Omega Healthcare Investors will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Monday, November 3rd were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.1%. The ex-dividend date of this dividend was Monday, November 3rd. Omega Healthcare Investors’s payout ratio is 149.72%.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, CIO Vikas Gupta purchased 11,500 shares of the stock in a transaction that occurred on Thursday, November 6th. The stock was purchased at an average cost of $42.97 per share, with a total value of $494,155.00. Following the completion of the acquisition, the executive directly owned 13,773 shares of the company’s stock, valued at $591,825.81. This trade represents a 505.94% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO C Taylor Pickett purchased 20,000 shares of the stock in a transaction that occurred on Wednesday, November 5th. The stock was acquired at an average cost of $43.14 per share, with a total value of $862,800.00. Following the completion of the acquisition, the chief executive officer directly owned 20,000 shares of the company’s stock, valued at $862,800. This represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 1.50% of the company’s stock.

Institutional Trading of Omega Healthcare Investors

Several institutional investors have recently modified their holdings of the stock. GeoWealth Management LLC grew its position in shares of Omega Healthcare Investors by 1.3% in the 3rd quarter. GeoWealth Management LLC now owns 18,850 shares of the real estate investment trust’s stock valued at $796,000 after buying an additional 239 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in Omega Healthcare Investors by 40.9% in the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after acquiring an additional 268 shares during the last quarter. Farther Finance Advisors LLC boosted its stake in Omega Healthcare Investors by 7.1% in the second quarter. Farther Finance Advisors LLC now owns 4,182 shares of the real estate investment trust’s stock valued at $153,000 after acquiring an additional 279 shares in the last quarter. Guggenheim Capital LLC grew its holdings in shares of Omega Healthcare Investors by 1.0% during the second quarter. Guggenheim Capital LLC now owns 29,398 shares of the real estate investment trust’s stock worth $1,077,000 after purchasing an additional 280 shares during the last quarter. Finally, CI Investments Inc. grew its holdings in shares of Omega Healthcare Investors by 19.8% during the third quarter. CI Investments Inc. now owns 1,715 shares of the real estate investment trust’s stock worth $72,000 after purchasing an additional 283 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.